from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2894c/xerC

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.783

Cap5-10ug/mL Capreomycintranslation

0.134

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.521

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.931

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.398

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.546

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.754

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.282

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.050

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.895

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.250

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.495

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.683

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.634

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.725

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.587

KCN5-20 ug/mL Potassium cyaniderespiration

0.650

NaN30.2-2 mM Sodium aziderespiration

-1.584

Nigericin50 uM Nigericinrespiration

0.451

TRC10-150 ug/mL Triclosanrespiration

-0.645

TRZ10-25 ug/mL Thioridazinerespiration

-1.192

Valinomycin0.5-10 uM Valinomycinrespiration

1.070

ZnSO42 mM ZnSO4respiration

-0.580

menadione6-10 ug/mL Menadionerespiration

1.258

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.318

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.000

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.626

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.504

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.549

Cephalexin20-100 ug/mL CephalexincellWall

0.071

Cerulenin0.32-5 ug/mL CerulenincellWall

0.119

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.088

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.228

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.112

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.403

BZA0.12 mg/mL BenzamidearomaticAmides

0.187

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.214

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.546

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.978

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.387

UVUV-irradiationDNAdamaging

-0.814

ARP41-4 ug/mL Antitubercular compound ARP4?

0.284

Antimycin12.5-50 ug/mL Antimycin A?

-0.288

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.000

PA_110-50 ug/mL Antitubercular compound PA-1?

0.000

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.700

PA8240.2-2 ug/mL PA-824?

0.785

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.551

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.501

Verapamil50 uM Verapamil?

-0.731

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.385

methoxatin10-20 ug/mL Methoxatin?